Fiscal Year End | Company Status | Exempt Flag |
December 31 | Delist | N |
|
|
|
|
|
Incorporation Locations |
Inc. Date | Expiry Date | Country | Region | Description |
3/Feb/2010 | 13/Dec/2020 | Canada | Ontario | |
|
|
Exchange Filing Office |
Location |
(not available) |
|
| |
Business Type(s) |
Primary/Secondary | Business Type | Details |
Primary
| *Health Care and Manufacturing and Distribution of Medical Devices
| News Release May 7, 2015-Annidis (TSX-V: RHA) has developed and is marketing a new imaging platform technology based on Multi-Spectral Imaging (MSI). This new technology is opening a new frontier in disease identification and its management. The Annidis MSI technology allows eye-care professionals to view non-invasively the deepest areas of the eye aiding eye care professionals in the early identification and treatment of debilitating eye diseases. The Corporation's existing RHA 2020-U Gold, used by eye care professionals as a broad based tool for detecting early-onset of eye related diseases such as Dry AMD, has a potential market of over 20,000 clinics in North America. The RHA Platinum MD will further strengthen the value proposition allowing doctors to visualize choroidal and retinal vasculature non-invasively.
|
| *Capital Pool Company
| (not available)
|
|
|
Securities |
Symbol | Security Name | Market | Status |
*RHA.H | *Annidis Corporation | TSX Venture | DELIST |
*RHA | *Annidis Corporation | TSX Venture | DELIST |
*ATO.P | *Aumento Capital Corporation | TSX Venture | DELIST |
|
|
Name History | From | To |
*Annidis Corporation | 13/Jun/2011 | 13/Dec/2020 |
*Aumento Capital Corporation | 7/Oct/2010 | 12/Jun/2011 |
|
|
Company Facts Reconciliation |
Subject | Date Returned |
Spring 2015 CFR | Not Received |
|
|
|
|